Editor-in-Chief:
Alexander J. Brucker, MD
ISSN:
0275-004X
Online ISSN:
1539-2864
Frequency:
12 issues per year
Ranking:
19/61 in Ophthalmology
Impact Factor:
3.3
OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion